Filter
543
Filtered Results: 543
Text search:
N.
B.
Ahmed
Featured
Recommendations
60
New Publications
111
Language
Document type
No document type
256
Studies & Reports
123
Guidelines
99
Manuals
32
Strategic & Response Plan
15
Fact sheets
8
Training Material
7
Infographics
2
Situation Updates
1
Countries / Regions
India
45
Bangladesh
18
Ethiopia
16
Global
13
Kenya
12
Russia
12
Nepal
11
Brazil
11
Africa
11
Nigeria
10
Western and Central Europe
10
South Africa
9
Senegal
7
Rwanda
6
Malawi
6
Uganda
5
Pakistan
5
Germany
5
Latin America and the Carribbean
5
Asia
5
South Sudan
4
Tanzania
4
East and Southern Africa
4
Burkina Faso
3
Zambia
3
Syria
3
Mozambique
3
Sudan
3
Ecuador
3
Middle East and North Africa
3
Eastern Europe
3
Guinea
2
Côte d’Ivoire / Ivory Coast
2
Ghana
2
Philippines
2
Afghanistan
2
Indonesia
2
Benin
2
Argentina
2
Angola
2
South–East Asia Region
2
Venezuela
2
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
Mali
1
Guinea-Bissau
1
Cameroon
1
Togo
1
Zimbabwe
1
Haiti
1
Turkey
1
Egypt
1
Chad
1
Cambodia
1
Central African Republic
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
Ukraine
1
Colombia
1
Honduras
1
Botswana
1
El Salvador
1
Bolivia
1
Guatemala
1
Lesotho
1
Mexico
1
Nicaragua
1
Myanmar / Burma
1
Sri Lanka
1
Chile
1
Yemen
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Paraguay
1
Tajikistan
1
Uruguay
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
176
Clinical Guidelines
64
Women & Child Health
41
Public Health
34
Key Resources
22
Pharmacy & Technologies
10
Capacity Building
2
Toolboxes
COVID-19
64
TB
49
Mental Health
39
HIV
36
Planetary Health
25
Disability
24
Caregiver
20
NTDs
20
AMR
17
Rapid Response
13
Ebola
10
Pharmacy
10
Natural Hazards
9
Refugee
9
Conflict
8
NCDs
8
Cholera
5
Polio
4
Zika
4
Global Health Education
4
Health Financing Toolbox
3
Typhoon
2
Social Ethics
2
Specific Hazards
1
Health Financing
1
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
scientific brief, 2 March 2022
This report - the largest of its kind to date - draws on the experiences of over 8,500 women and 300 health professionals across eight countries. It exposes the aggressive marketing practices used by the formula milk industry, and highlights impacts on families’ decisions about how to feed their b...
The emergence and transmission of zoonotic diseases are driven by complex interactions
between health, environmental, and socio-political systems. Human movement is considered
a significant and increasing factor in these processes, yet forced migration remains an
understudied area of zoonotic res...
The Lancet. 13 March 2022. doi: 10.1016/S0140-6736(21)02868-3. Previous Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) studies have reported
national health estimates for Ethiopia. Substantial regional variations in socioeconomic status, population, demography, and access to hea...
Brucellosis is widespread in both humans and livestock in many developing countries. The authors have performed a series of epidemiological studies on brucellosis in agro-pastoral areas in Tanzania since 2015, with the aim of the disease control. Previously, the potential of a community-based brucel...
Clinical Microbiology and Infection Volume 21, Issue 5, May 2015, Pages 433-443;
The neglected zoonotic diseases (NZDs) have been all but eradicated in wealthier countries, but remain major causes of ill-health and mortality across Africa, Asia, and Latin America. This neglect is, in part, a conse...
Tuberculosis (TB) is an infectious disease that usually affects the lungs, though it can affect any organ in the body. It can develop when bacteria spread through droplets in the air. TB can be fatal, but in many cases, TB is preventable and treatable. This report examines the human rights impact of...
In the light of the transmissibility of coronaviruses, and the global experience with MERS-CoV (ongoing) and SARS in 2003 which were also caused by coronaviruses, South African authorities have compiled this guideline document to support surveillance, case finding, diagnosis, management and public h...
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given that a vaccine will eventually be produced, informa...
Guía de tratamiento farmacológico y manejo deescenarios clínicos de casos de COVID-19 – enero 2022 Guía de tratamiento farmacológico y manejo deLeer más
Curr HIV/AIDS Rep. 2022; 19(1): 37–45.
Published online 2022 Jan 29. doi: 10.1007/s11904-021-00589-4.
COVID-19 has had an unprecedented impact on the cascade-of-care among PLWH in LAC. There is a need for
longitudinal studies that assess clinic implication of these pandemic interactions in LAC.
Fact Sheet Global Atlas of medical devices
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality...
Sector Environmental Guidelines, Full technical Update
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
